NCT04435197 2024-07-03
PALACE-2
Ruijin Hospital
Phase 2 Completed
Clinical Trials
9 trialsNCT02233374 2022-10-28
PRISM
Royal North Shore Hospital
Phase NA Completed
NCT05534841 2022-09-10
Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Centre Hospitalier Universitaire de NÄ«mes
Completed
NCT04939103 2022-09-01
TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Completed
NCT01648894 2022-07-25
GRECCAR6
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT04271657 2021-05-06
RPAI-pCR
Sixth Affiliated Hospital, Sun Yat-sen University
Completed
NCT01216644 2019-06-19
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Krankenhaus Nordwest
Phase 2/3 Completed
NCT03601689 2018-07-26
Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma
Moroccan Society of Surgery
Completed
NCT02353858 2018-02-13
HT01
University Hospital Tuebingen
Phase 2 Completed